Treatment of Insomnia in a 76-Year-Old Female Related to Anxiety
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for this 76-year-old female with anxiety-related insomnia, with pharmacological options reserved only if CBT-I alone is unsuccessful. 1, 2
First-Line Treatment: CBT-I
CBT-I is the gold standard non-pharmacological treatment with strong evidence supporting its efficacy in older adults with insomnia, including those with comorbid anxiety. It produces results equivalent to sleep medication without side effects, with fewer episodes of relapse, and continued improvement after treatment ends 3, 4.
The multicomponent CBT-I approach includes:
Stimulus Control 1:
- Go to bed only when sleepy
- Get out of bed when unable to sleep
- Use bed/bedroom only for sleep and sex
- Wake up at the same time every morning
- Refrain from daytime napping
Sleep Restriction Therapy 1:
- Limit time in bed to match actual sleep time
- Gradually increase time in bed as sleep efficiency improves
- Initially may be challenging but highly effective
Relaxation Training 1:
- Progressive muscle relaxation
- Deep breathing exercises
- Guided imagery
- Particularly helpful for anxiety-related insomnia
Cognitive Therapy 1:
- Address unhelpful beliefs about sleep
- Challenge catastrophic thinking about consequences of poor sleep
- Reduce performance anxiety about sleeping
Sleep Hygiene Education 1:
- Regular sleep schedule
- Comfortable sleep environment
- Avoid caffeine, alcohol, and stimulating activities before bedtime
- Morning exposure to bright light
Second-Line Treatment: Pharmacotherapy
If CBT-I alone is unsuccessful after 4-8 weeks of consistent implementation, consider adding pharmacotherapy through shared decision-making 1, 2:
Preferred Medications for Elderly Patients:
Low-dose Doxepin (3-6mg) 1, 2:
- First choice for elderly with anxiety-related insomnia
- Particularly effective for sleep maintenance
- Lower risk of falls and cognitive impairment
- Improves sleep efficiency in the final third of the night
- Melatonin receptor agonist
- Useful for sleep onset insomnia
- No risk of dependence
- Minimal next-day effects
- Consider for comorbid depression and anxiety
- Evidence is relatively weak compared to other options
- Monitor for orthostatic hypotension
Medications to Use with Caution:
Zolpidem (5mg for elderly) 1, 5:
- Use only short-term (≤4 weeks)
- Effective for sleep onset insomnia
- Risk of falls, cognitive impairment, and dependence
- May cause anterograde amnesia
Eszopiclone (1-2mg for elderly) 1, 2:
- Use only short-term (≤4 weeks)
- Effective for sleep maintenance
- Risk of falls and cognitive impairment
Benzodiazepines:
- Generally avoid in elderly due to increased risk of falls, cognitive impairment, and dependence
- If used, consider shorter-acting options like temazepam at lowest effective dose
Important Considerations for Elderly Patients:
- Start Low, Go Slow: Begin with the lowest effective dose of any medication
- Short-Term Use: Limit pharmacological treatment to 4-5 weeks 1
- Monitor Closely: Assess for side effects, particularly daytime sedation, falls, and cognitive changes
- Follow-Up: Schedule follow-up within 2-4 weeks of starting any treatment 2
- Combination Approach: If using medication, continue CBT-I throughout treatment and during medication tapering 3
Treatment Algorithm:
- Start with CBT-I for 4-8 weeks
- If inadequate response, add pharmacotherapy while continuing CBT-I:
- For sleep onset problems: Ramelteon 8mg
- For sleep maintenance: Low-dose doxepin 3-6mg
- Monitor response every 2-4 weeks
- If using hypnotics, plan for tapering after 4-5 weeks while continuing CBT-I
For this 76-year-old female with anxiety-related insomnia, the evidence strongly supports starting with CBT-I, which addresses both the insomnia and can help with anxiety symptoms 6, 7. The non-pharmacological approach is particularly important in elderly patients to avoid medication-related adverse effects.